ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 128 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,856,969 | +23.5% | 10,934,530 | +6.7% | 1.20% | +19.7% |
Q1 2023 | $7,174,444 | +18.6% | 10,249,206 | +19.6% | 1.00% | +9.9% |
Q4 2022 | $6,050,238 | -45.5% | 8,569,742 | +17.3% | 0.91% | -50.5% |
Q3 2022 | $11,100,000 | +180.8% | 7,302,956 | +83.4% | 1.84% | +192.2% |
Q2 2022 | $3,953,000 | +82.8% | 3,982,264 | +165.2% | 0.63% | +125.4% |
Q1 2022 | $2,162,000 | -58.9% | 1,501,441 | +48.9% | 0.28% | -57.2% |
Q4 2021 | $5,264,000 | -27.9% | 1,008,341 | -19.4% | 0.65% | -29.9% |
Q3 2021 | $7,296,000 | -35.6% | 1,251,513 | -10.9% | 0.93% | -31.6% |
Q2 2021 | $11,322,000 | +0.2% | 1,404,761 | +3.4% | 1.36% | -5.5% |
Q1 2021 | $11,304,000 | +1.5% | 1,358,644 | -7.6% | 1.44% | -2.2% |
Q4 2020 | $11,141,000 | -27.4% | 1,469,820 | +2.1% | 1.48% | -37.4% |
Q3 2020 | $15,346,000 | -27.4% | 1,439,613 | +3.3% | 2.36% | -30.2% |
Q2 2020 | $21,134,000 | +82.5% | 1,394,052 | +0.3% | 3.38% | +54.2% |
Q1 2020 | $11,581,000 | -31.1% | 1,390,227 | +39.8% | 2.19% | -6.9% |
Q4 2019 | $16,810,000 | +11.1% | 994,657 | +22.1% | 2.36% | +0.3% |
Q3 2019 | $15,130,000 | +20.2% | 814,749 | +48.1% | 2.35% | +46.8% |
Q2 2019 | $12,585,000 | +23.5% | 550,046 | +13.4% | 1.60% | +11.0% |
Q1 2019 | $10,192,000 | +103.0% | 484,871 | +11.1% | 1.44% | +70.2% |
Q4 2018 | $5,020,000 | -13.5% | 436,519 | +72.6% | 0.85% | -0.8% |
Q3 2018 | $5,804,000 | – | 252,893 | – | 0.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |